Maria JoseSoler BarcelonaSpain

• AKI Due to Chemotherapy
  Diana CarolinaVargas Angel Speaker Colombia
• AKI Due to Targeted Therapy
  MotokoYanagita Speaker Japan
• AKI Due to Immunotherapy
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• Roundtable Discussion
  KenarJhaveri Moderator Kjhaveri@northwell.eduUnited States

• Hyponatremia in Patients with Cancer
  SanjeevNair Speaker India
• Hypercalcemia in Patients with Cancer
  MohamedHassanein Speaker Egypt
• Hypomagnesemia and Hypophosphatemia in Patients With Cancer
  JolantaMalyszko Speaker Poland
• Roundtable Discussion
  KenarJhaveri Moderator Kjhaveri@northwell.eduUnited States

• Onco-nephrology in the Kidney Transplant Population
  RobertCarroll Speaker robert.carroll@health.sa.gov.auAustralia
• Onco-Hypertension: Mechanisms, Monitoring, and Management
  SabineKaram Speaker sabinejkaram@gmail.comUnited States
• GFR Estimation in Patients With Cancer
  ShuchiAnand Speaker sanand3@health.ucdavis.eduUnited States
• Q&A and Final Remarks
  KenarJhaveri Moderator Kjhaveri@northwell.eduUnited States

• Welcome & Introduction
  MotokoYanagita Speaker Japan
• Orchestrating Excellence: KDIGO’s Guidance on the Management of IgA Nephropathy
  Sydney Tang Speaker Hong Kong, China
• Setting the Tempo: The Importance of Early Diagnosis and Treatment in IgA Nephropathy
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• A Harmonious Approach: Simultaneously Targeting Both Drivers
  VladoPerkovic Speaker Australia
• A Note of Hope: Reimagining the Outcomes for Patients With IgA Nephropathy
  MotokoYanagita Speaker Japan
• Summary & Close
  MotokoYanagita Speaker Japan

• Cancer Screening in Kidney Transplant Recipients and Dialysis Patients
  Chi Yuen SimonCheung Speaker Hong Kong, China
• Chronic Kidney Disease After Childhood Cancer
  Maria JoseSoler Speaker mjsoler01@gmail.comSpain
• Roundtable Discussion